Journalistic Rewrite: Lunit has acquired the breast cancer detection AI company, Volpara Health.

Q: How long will it take to read this news story?

The story " Journalistic Rewrite: Lunit has acquired the breast cancer detection AI company, Volpara Health." has 379 words across 19 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story " Journalistic Rewrite: Lunit has acquired the breast cancer detection AI company, Volpara Health." was covered 3 weeks ago by Korea Economic Daily, a news publisher based in South Korea.

Q: How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news. The outlet is headquartered in South Korea and publishes an average of 0 news stories per day. It's most recent story was published 1 days ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21056457</li><li>URL: https://beamstart.com/news/lunit-buys-breast-cancer-detection-17163654719803</li></ul>

Korea Economic Daily Logo Korea Economic Daily 3w ago

Journalistic Rewrite: Lunit has acquired the breast cancer detection AI company, Volpara Health. - Korea Economic Daily

Quick Summary:

Kosdaq-listed Lunit acquired the full ownership of Volpara.“Lunit integrates Volpara’s advanced breast health platform such as breast density assessment, Scorecard™ and screening workflow enhancement with its AI-powered solutions for breast cancer detection,” Lunit said in a press release.

Volpara Scorecard refers to an AI software used to assess breast tissue composition.“While our initial focus remains on breast cancer, both Lunit and Volpara are committed to broadening our offerings to address a wider range of cancers and medical conditions,” said Brandon Suh, chief executive of Lunit.

Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI software developer for breast cancer detection, for 264.7 billion won ($194 million), the two companies said on Wednesday.